MeSH term
Frequency | Condition_Probility | Female | 8 | 0.0 |
Humans | 33 | 0.0 |
Pregnancy | 2 | 0.0 |
*Adaptor Proteins, Vesicular Transport | 19 | 7.0 |
Adult | 3 | 0.0 |
Aged | 3 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Epithelial Cells/pathology | 3 | 3.0 |
*Genes, Tumor Suppressor | 3 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Middle Aged | 3 | 0.0 |
Proteins/*genetics | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Animals | 19 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Rats | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Mice | 11 | 0.0 |
K562 Cells | 4 | 0.0 |
Trans-Activators/genetics | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Adaptor Proteins, Vesicular Transport/metabolism | 3 | 20.0 |
Blotting, Western | 3 | 0.0 |
Comparative Study | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Cell Differentiation | 4 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Flow Cytometry | 2 | 0.0 |
MAP Kinase Signaling System | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-fos/*metabolism | 2 | 5.0 |
Signal Transduction | 5 | 0.0 |
Time Factors | 2 | 0.0 |
Transfection | 6 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA | 2 | 0.0 |
Binding Sites | 4 | 0.0 |
Cell Line | 7 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Proteins/chemistry/genetics/*metabolism | 2 | 2.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
src Homology Domains | 2 | 0.0 |
Chromosomes, Artificial, Bacterial | 2 | 2.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Phosphorylation | 4 | 0.0 |
Proteins/genetics/*physiology | 2 | 1.0 |
3T3 Cells | 2 | 0.0 |
Clathrin/metabolism | 2 | 4.0 |
Endocytosis/*physiology | 4 | 3.0 |
Peptides/genetics/metabolism | 2 | 4.0 |
Cell Adhesion | 2 | 0.0 |
Protein Binding | 9 | 0.0 |
Basement Membrane | 2 | 11.0 |
Ovarian Neoplasms/*pathology | 2 | 3.0 |
*Proteins | 4 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Ligands | 3 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Ovary/pathology | 2 | 6.0 |
*Genes, MHC Class II | 2 | 0.0 |
Phylogeny | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Endocytosis | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
